Mast Cell‐Derived CXCL4: A Key Mediator of Ferroptosis and Cardiac Damage in Septic Cardiomyopathy
Immunity, Inflammation and Disease · 2026-03 · 14 (3)
DOI: 10.1002/iid3.70359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 07.03.2026. Verfasst von Jing Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Jiangning Hospital Affiliated to Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Ferroptosis, Mast Cells, Sepsis, Cardiomyopathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Research Topics on the Development of Medical Science and Technology in Nanjing, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Septic cardiomyopathy (SCM) is a common and life‐threatening complication of severe sepsis, with high mortality due to unclear underlying mechanisms. CXCL4, a key pro‐inflammatory factor, is implicated in various heart diseases, while ferroptosis (iron and lipid hydrogen peroxide‐dependent regulated cell death) plays a crucial role in SCM progression. However, the specific crosstalk between CXCL4, ferroptosis, and SCM remains unelucidated.
Methods
BALB/c mice were randomly divided into six groups (Control, LPS, LPS + Sodium Cromoglycate (CS), LPS + Ferrostatin‐1 (Fer‐1), LPS + Pifithrin‐α (PFT‐α), LPS + Niclosamide) to establish the SCM model via intraperitoneal LPS injection. In vivo experiments included histopathological examination (H&E, toluidine blue staining), survival analysis, ELISA, Western blot, immunofluorescence, immunohistochemistry, TUNEL staining, and detection of myocardial markers (CK‐MB, AST, LDH) and oxidative stress indicators (SOD, MDA, iron content). In vitro, RAW264.7 macrophages were treated with CXCL4 alone or combined with inhibitors (Fer‐1, PFT‐α, Niclosamide), followed by CCK‐8 assay, ROS detection, qRT‐PCR, Western blot, and phagocytosis microbead assay.
Results
In vivo, SCM mice exhibited significantly elevated CXCL4 levels in serum and heart tissue, accompanied by mast cell activation and degranulation. Inhibiting mast cell activation (with CS) reduced CXCL4 production, alleviated cardiac inflammation and ferroptosis (increased SLC7A11/GPX4 expression, decreased 4‐HNE), and improved survival. TUNEL staining revealed predominant macrophage death in SCM hearts. In vitro, CXCL4 induced macrophage ferroptosis (downregulated SLC7A11/GPX4) and impaired phagocytic function (reduced CD36/MERTK expression), which was reversed by Fer‐1. Mechanistically, CXCL4 activated STAT3 phosphorylation, regulating downstream P53; inhibiting STAT3 (Niclosamide) or P53 (PFT‐α) alleviated macrophage ferroptosis, restored phagocytosis, and mitigated cardiac injury in SCM mice.
Conclusion
Mast cell‐derived CXCL4 induces macrophage ferroptosis via the STAT3/P53 signaling pathway, impairs macrophage phagocytic function, and exacerbates myocardial injury in SCM. Targeting mast cell activation, CXCL4 release, or the STAT3/P53‐ferroptosis axis may serve as promising therapeutic strategies for SCM. Clinical trial number: Not applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Jiangning Hospital Affiliated to Nanjing Medical University, Nanjing, China.
- Department of Laboratory Medicine, Nanjing First Hospital, Nanjng Medical University, Nanjing, China.
ORCID-Profile: Hong-Xiang Lu
Förderung
- General Research Topics on the Development of Medical Science and Technology in Nanjing
- National Natural Science Foundation of China
Zitieren
APA
Wei, J., Jiang, Z. Y., Ye, L. F., & Lu, H. X. (2026). Mast Cell‐Derived CXCL4: A Key Mediator of Ferroptosis and Cardiac Damage in Septic Cardiomyopathy. Immunity, Inflammation and Disease, 14(3). https://doi.org/10.1002/iid3.70359
Vancouver
Wei J, Jiang ZY, Ye LF, Lu HX. Mast Cell‐Derived CXCL4: A Key Mediator of Ferroptosis and Cardiac Damage in Septic Cardiomyopathy. Immunity, Inflammation and Disease. 2026;14(3). doi:10.1002/iid3.70359
BibTeX
@article{Wei2026,
author = {Wei, Jing and Jiang, Zhi-Ying and Ye, Ling-Feng and Lu, Hong-Xiang},
title = {Mast Cell‐Derived CXCL4: A Key Mediator of Ferroptosis and Cardiac Damage in Septic Cardiomyopathy},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {3},
doi = {10.1002/iid3.70359}
}
EUVIMED